Finance

Lists
DSGN:NASDAQ
Design Therapeutics Inc
11,65 US$
+1,39%
(+0,16) 1D
11,65 US$
0,00% (0,00)
After hours
Closed: 9 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DSGN...
Open
11,47 US$
High
11,92 US$
Low
11,40 US$
Mkt. cap
729,08 მლნ.
Avg. vol.
708,32 ათ.
Volume
356,59 ათ.
52-wk high
17,25 US$
52-wk low
5,28 US$
EPS
-1,18 US$
Beta
1,68
Shares outstanding
62,58 მლნ.
No. of employees
55
Open
11,47 US$
High
11,92 US$
Low
11,40 US$
Mkt. cap
729,08 მლნ.
Avg. vol.
708,32 ათ.
Volume
356,59 ათ.
52-wk high
17,25 US$
52-wk low
5,28 US$
EPS
-1,18 US$
Beta
1,68
Shares outstanding
62,58 მლნ.
No. of employees
55
News stories
From web sources and news partners
About Design Therapeutics Inc
CEO-
Employees55
Founded2017
Headquartersკარლსბადი, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to DSGN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for DSGN in the last 3 months.
Highest
Current 11,65 US$
40,54 US$ (+247,98%)
Average
27,14 US$ (+132,96%)
Lowest
20,00 US$ (+71,67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tianqi Hang
Wells Fargo
Buy
Initiated
26,00 US$
+123,2%
10/02/2026
Unknown Analyst
Wells Fargo
Buy
Initiated
26,00 US$
+123,2%
10/02/2026
Unknown Analyst
Cantor Fitzgerald
Buy
Maintained
40,54 US$
+248%
08/05/2026
Adam Vogel
Craig-Hallum
Buy
Maintained
22,00 US$
+88,8%
08/04/2026
Leonid Timashev
RBC Capital
Buy
Maintained
20,00 US$
+71,7%
08/03/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
21,00 US$
+80,3%
06/15/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
20,00 US$
+71,7%
05/27/2026
Faisal Khurshid
Jefferies
Buy
Initiated
15,00 US$
+28,8%
03/15/2026
Luca Issi
RBC Capital
Buy
Reiterated
14,00 US$
+20,2%
03/09/2026
Last report
3 აგვ. 2026
Fiscal period
Q2 2026
-0,32 US$ / -0,34 US$
+7,06%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
14,59 მლნ.
13,42 მლნ.
14,38 მლნ.
16,39 მლნ.
Cost of revenue
14,59 მლნ.
13,42 მლნ.
14,38 მლნ.
16,39 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,72 მლნ.
4,74 მლნ.
5,33 მლნ.
5,79 მლნ.
Operating expense
4,72 მლნ.
4,74 მლნ.
5,33 მლნ.
5,79 მლნ.
Total operating expenses
19,31 მლნ.
18,17 მლნ.
19,71 მლნ.
22,18 მლნ.
Operating income
-19,31 მლნ.
-18,17 მლნ.
-19,71 მლნ.
-22,18 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-17,00 მლნ.
-16,00 მლნ.
-17,64 მლნ.
-20,16 მლნ.
EBT excluding unusual items
-17,00 მლნ.
-16,00 მლნ.
-17,64 მლნ.
-20,16 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17,00 მლნ.
-16,00 მლნ.
-17,64 მლნ.
-20,16 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,30
-0,27
-0,29
-0,32
Interest and investment income
2,31 მლნ.
2,17 მლნ.
2,07 მლნ.
2,01 მლნ.
Interest expense
-
-
-
-
Net interest expenses
2,31 მლნ.
2,17 მლნ.
2,07 მლნ.
2,01 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-19,16 მლნ.
-18,01 მლნ.
-19,55 მლნ.
-22,03 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები